Stents Market Size By Product (Vascular Stents [Coronary Stents {Bare Metal Stents, Drug Eluting Stents, Bioresorbable Stents}, Peripheral Stents {Iliac Stents, Femoral-popliteal Stents, Renal Stents, Carotid Stents}, Neurovascular Stents], Non-vascular Stents), By Material (Metal, Polymer), By Type (Self-expandable Stents, Balloon-expandable Stents), By End-use (Hospitals, Ambulatory Surgical Centers), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Nov 2019  |  Report ID: GMI3372  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 300   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry trends

Stent Market size surpassed USD 9.5 billion in 2018 and is forecast to register more than 5.3% CAGR up to 2025.
 

Stent Market

Get more details on this report - Request Free Sample PDF
 

A stent is a wire mesh tube that is inserted into the blocked or narrowed artery. It is needed only when more than 70% of the artery is blocked or narrowed due to deposition of plaque. Stents can be lifesaving in those instances where the blood flow is completely blocked due to the formation of blood clot in a partially clogged artery. With the various technological advancements in the stenting procedure, many patients are able to resume daily activities within a few days or a week’s time.
 

Although stents were introduced in the late 1980’s, the stent technology has evolved tremendously in the past 20 years. As the mesh design is more flexible, insertion of stents is comparatively easier than the conventional ones. The flexible design also limits the growth of scar tissue and prevents the re-narrowing of the artery. The industry share is rapidly growing in the Asia Pacific region due to large patient population base along with various government initiatives and favorable regulations. All these opportunities in the market will witness influx of new entrants that develop novel products with innovative design and concept.
 

Stents Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 9.5 Billion (USD)
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 5.3% 2025 Value Projection: 14 Billion (USD)
Pages: 300 Tables, Charts & Figures: 718
Geographies covered (14): U.S., Canada, Germany, UK, France, Spain, Italy, China, Japan, India, Australia, Singapore, Brazil, Mexico, South Africa, Saudi Arabia
Segments covered: Product, Material, Type, End-use and Region
Companies covered (11): Abbott Laboratories, B. Braun Melsungen AG, Biosensors International Group, Biotronik SE & Co. KG, Boston Scientific, C R Bard, Elixir Medical Corporation, Medtronic Plc, Meril Life Sciences, MicroPort Scientific Corporation, Stryker, Terumo, Veryan Medical Limited, W.L. Gore & Associates
Growth Drivers:
  • Growing cardiovascular disorders
  • Rising demand for minimally invasive procedures
  • Advancement in healthcare technology
  • Unhealthy and hectic lifestyle
  • Growing geriatric population
Pitfalls & Challenges:
  • Stent failure and recall
  • Stringent regulatory approvals

Get more details on this report - Request Free Sample PDF
 

High pervasiveness of coronary artery disease will spur the market growth

Rising number of cardiovascular surgeries coupled with increasing adoption of minimally invasive techniques are the major factors stimulating industry growth. Increasing consumption of suboptimal diet along with rise in the adoption of sedentary lifestyle are the major factors leading to increase in patient population. For instance, about 31% of the global deaths in 2016 were due to cardiac disorders. As increasing number of people are being diagnosed with coronary heart disease, the market demand for peripheral coronary intervention procedure will increase, thereby propelling business growth in the future.
 

However, complications pertaining to stent implantation may hinder the industry growth in the future. Also, product recalls due to safety issues might limit the growth of stents market across the forecast timeframe.
 

Vascular stents will capture majority of the market share

Stents Market By Product

Get more details on this report - Request Free Sample PDF
 

By product, the market outlook is segmented into vascular and non-vascular stents. Vascular stents include coronary stents, peripheral stents and neurovascular stents and accounted for majority of the market share in 2018. High growth rate is attributed to increasing market demand of vascular stents in cardiovascular and elderly patients. Also, factors such as various government policies and expanding product portfolio of companies will be conducive to market growth in the future.
 

Metal is the most common material for stent production

Based on material, the stents market is categorized into metal and polymer. Metal stents accounted for revenue share of about 81% in 2018. Metal is the most preferred material for production of stents due to various advantages associated with it. Enhanced flexibility and biocompatibility are few of the attributes of metallic stents that is driving the market demand. Also, various companies are integrating metallic stents with biodegradable polymers to overcome the limits of conventional metallic stents. The aforementioned factors will significantly drive the market growth in the future.
 

Balloon-expandable Stents have become the stents of choice in the coronary arteries

Based on type, the stent market is bifurcated into Self-expandable Stents and Balloon-expandable Stents. Balloon-expandable Stents accounted for revenue of USD 6.3 billion in 2018. Better radial stiffness, increasing approvals for Balloon-expandable Stents and high adoption rate will spur segmental market growth. Also, majority of the modern and advanced Balloon-expandable Stents avoid chronic recoil and hyperplasia, thereby making them the stent of choice for percutaneous coronary intervention. Other advantages such as long-term mechanical integrity and higher elasticity will prove to be beneficial for market expansion in the future.

Supply agreements between hospitals and manufacturers will significantly drive industry statistics

Based on end-use, the stent market is segmented into hospitals and ambulatory surgical centers. Hospitals as an end-use are projected to significantly expand at 5.2% CAGR across the projected years. High growth is attributable to rising supply agreements of stents between manufacturing firms and hospitals. Also, due to the presence of state-of-the-art facilities, patients prefer hospital settings. Increasing number of surgical procedures in hospitals due to growing number of patients and availability of skilled healthcare personnel will be another chief factor in augmenting the market growth.
 

Availability of stents at affordable prices in major countries of Asia Pacific region will boost market growth

Asia Pacific Stents Market By Country

Get more details on this report - Request Free Sample PDF
 

Asia Pacific stents industry size is anticipated to show significant growth of 6.7% during the projected timeframe. Large patient population suffering from cardiovascular disorders coupled with various government initiatives will drive the market growth. For instance, as per the statistics, in China, more than 93 million people were diagnosed with cardiac disorders in 2016. To cater to the needs of the growing patient population, government is undertaking various strategies to provide affordable treatment options. Also, various major players are entering the Chinese stents market space to gain larger market share.
 

India stents market statistics accounted for significant revenue share in 2018. Various government policies and large patient population base will foster business growth in the future. The local manufacturers market share has significantly grown after the price capping of bare metal stents and drug eluting stents in 2017. Also, with presence of affordable treatment options, the adoption of stents has grown exponentially among the Indian patients. Aforementioned factors will significantly drive the coronary stents industry growth in the country.
 

Companies are gaining new product approvals for business expansion

Few of the notable players operating in the industry are Abbott, B Braun, Biosensors, Biotronik, Boston Scientific, Medtronic, Stryker and Terumo. Novel product launches, mergers, acquisitions and geographic expansion are few of the strategies adopted by these companies to expand the customer base.
 

Recent industry developments:

  • In February 2019, Biotronik received U.S. FDA approval for its Orsiro drug eluting stent that is an ultrathin and bioresorbable stent. The product is intended for percutaneous coronary intervention (PCI) procedures. This new product launch enabled the company to strengthen its market presence and expand the existing customer base.
     
  • In November 2018, WL Gore and Associates received U.S. FDA approval for Gore carotid stent. The product is intended for re-opening the narrowed carotid arteries responsible for supplying blood to the brain. This new product launch enabled the company to strengthen its market hold in the U.S.  
     

Stents market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD and volume in units from 2014 to 2025, for the following segments:

By Product

  • Vascular stents
    • Coronary stents
      • Bare metal stents
      • Drug eluting stents
      • Bioresorbable stents
    • Peripheral stents
      • Iliac stents
      • Femoral-popliteal stents
      • Renal stents
      • Carotid stents
    • Neurovascular stents
  • Non-vascular stents

By Material

  • Metal
  • Polymer

By Type

  • Self-expandable Stents
  • Balloon-expandable Stents

By End-use

  • Hospitals
  • Ambulatory Surgical centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • Singapore
  • Latin America
    • Brazil
    • Mexico
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Frequently Asked Questions (FAQ) :

The market size of stents exceeded USD 9.5 billion in 2018.
The industry share of stents is set to achieve more than 5.3% CAGR up to 2025.
A stent is a wire mesh tube that is inserted into the blocked or narrowed artery. It is needed only when more than 70% of the artery is blocked or narrowed due to deposition of plaque.
The increasing prevalence of coronary and peripheral artery disease is driving the global market growth for stents.
Abbott, B Braun, Biosensors, Biotronik, Boston Scientific, Medtronic, Stryker and Terumo are the key players operating in the global industry for stents.

Buy NowImmediate delivery available

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Premium Report Details

  • Published Date: Nov 2019
  • Pages: 300
  • Tables: 708
  • Charts / Figures: 10
  • Companies covered: 11
  • Countries covered: 14

Benefits of Association

Data Coverage & Quality

GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.

Client Trust & Security

GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.

Customer Service

Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.

GMIPulse, our report store

We have introduced ‘GMIPulse’, which is our report store; designed to offer clients a one-stop platform for all market research and business intelligence requirements. Clients can access reports, presentations, raw data excel sheets as well as detailed company profiles. GMIPulse allows you to track relevant industries and stay informed with latest innovation, competitive and regulatory developments to help design strategic framework.

Chat with us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X